Welcome to the 2024 ISPE Annual Conference.

**Please Note: Listed times are for the Central European Summer Time (CEST)**

INSTRUCTIONS

INSTALL ZOOM IN ADVANCE

You will be using Zoom to watch the live stream sessions. For the best experience, you are encouraged to install the desktop application in advance, which you can find by clicking here. A registered Zoom account is NOT required to connect and stream sessions.

ACCESSING INDIVIDUAL SESSIONS

Click on the session that you would like to view. You will be prompted to add your name and email and click “register.” After you click register, if the session has not yet begun, you will see a “holding message” until the sessions starts.

If you need to re-join a session, close Zoom and click again on the session link located on the ISPE webpage. Anytime you join a Zoom session, you will be asked to re-enter your details.

Zoom’s Chat function cannot be used to direct questions to presenters on-site in Berlin. The Chat is purely for attendees connected to the live stream channel.

TECHNICAL ISSUES

If you have any technical difficulties during the session, please visit our support page.

Plenary Session 1

8:00 AM – 9:45 AM CEST

Welcome to ISPE 2024 and Keynote Session: The future of pharmacoepidemiology, powered by technology

Symposia & Workshops: Session 1

10:30 AM – 12:00 PM CEST

Evaluation of data quality in multi-database pharmacoepidemiologic studies: current practices and future trends

10:30 AM – 12:00 PM CEST

Estimating the Effects of Chronic Medications: Questions to Ask and Tools to Help Answer Them

10:30 AM – 12:00 PM CEST

Confounding control in high-throughput studies – principles and applications

10:30 AM – 12:00 PM CEST

Prevalent New User Designs: State of the Science and Considerations for Complex Clinical Scenarios

10:30 AM – 12:00 PM CEST

Methodological guidance for real world evidence to assess the effects of deprescribing

10:30 AM – 12:00 PM CEST

From a Pill to the Planet: Addressing Healthcare Sustainability through Pharmacoepidemiologic Research

10:30 AM – 12:00 PM CEST

Applications of trajectory methods in medication adherence research: A decade in review and a look ahead

Oral Presentations: Session 1

1:30 PM – 3:00 PM CEST

The Treatment and Prevention of Pregnancy-related Infections

1:30 PM – 3:00 PM CEST

Growing Old Gracefully

1:30 PM – 3:00 PM CEST

Cardiovascular Treatments and Outcomes

1:30 PM – 3:00 PM CEST

Cardiovascular Treatments and Outcomes:  Association between Denosumab and Risk of Cardiovascular Events in Patient with Osteoporosis: A Target Trial Emulation Study with Clone-Censor-Weight Approach

1:30 PM – 3:00 PM CEST

Hey! Please Control Yourself!

1:30 PM – 3:00 PM CEST

Vaccine Safety Across Ages & Platforms

1:30 PM – 3:00 PM CEST

Drugs and Alcohol Disorders

1:30 PM – 3:00 PM CEST

EmBRACEing Collaborations for Benefit-Risk Decision Making

Symposia & Workshops: Session 2

3:30 PM – 5:00 PM CEST

Advancing Drug Safety Signal Management through Multimodal Approaches in Networking

3:30 PM – 5:00 PM CEST

Specification of Time Zero in Causal Inference Studies Using Real-World Data: Challenges and Solutions.

3:30 PM – 5:00 PM CEST

Avoidable Bias in Real-World Evidence Studies on Treatment Effects: How to Detect and Prevent It

3:30 PM – 5:00 PM CEST

Addressing RWE Transportability Concerns in Health Care Decision-Making. How to Do It Right?

3:30 PM – 5:00 PM CEST

Natural Language Processing in Pharmacoepidemiology: Lessons from the Multi-source Observational Safety study for Advanced Information Classification using NLP (MOSAIC-NLP)

3:30 PM – 5:00 PM CEST

Real-world data-based external control for assessing long-term benefit-risk of cell and gene therapies: insights and perspectives

3:30 PM – 5:00 PM CEST

The Hidden Role Of AI In Treatment Selection: Friend Or Foe To The Study And Practice Of Pharmacoepidemiology?

Oral Presentations: Session 2

5:15 PM – 6:45 PM CEST

Safety of Anti-infectives

5:15 PM – 6:45 PM CEST

On Optimizing Outcomes for Older Adults

5:15 PM – 6:45 PM CEST

Considerations for Your Cardiovascular Study Design

5:15 PM – 6:45 PM CEST

Don’t Be Biased!

5:15 PM – 6:45 PM CEST

CV Risk Post-Vaccine Exposure

5:15 PM – 6:45 PM CEST

Mood Meds Mix: A Balancing Act

5:15 PM – 6:45 PM CEST

Lightning Session 1

Oral Presentations: Session 3

8:00 AM – 9:30 AM CEST

Psychotropics and Pregnancy: Timing Matters

8:00 AM – 9:30 AM CEST

Can We De-risk the Risk? Drug Exposure in Older Adults

8:00 AM – 9:30 AM CEST

Harms of Incretin-based Therapies for Diabetes Treatment

8:00 AM – 9:30 AM CEST

PS – There Are Others

8:00 AM – 9:30 AM CEST

Assessing COVID-19 Vaccine Effectiveness

8:00 AM – 9:30 AM CEST

Opioid Odyssey

8:00 AM – 9:30 AM CEST

The Evolving Landscape of Drug Safety: Research, Reporting, and Real-World Outcomes

Plenary Session 2

10:00 AM – 11:30 AM CEST

Role of Real World Data for Regulatory Science when Randomized Clinical Trials are Not ‎Feasible: Lessons Learned from Perinatal Pharmacoepidemiology

Oral Presentations: Session 4

1:00 PM – 2:30 PM CEST

Pregnancy Potpourri

1:00 PM – 2:30 PM CEST

Navigating the Cancer Landscape Using Innovative Pharmacoepidemiologic Methods

1:00 PM – 2:30 PM CEST

Your Brain on CVD and Diabetes Drugs

1:00 PM – 2:30 PM CEST

Move Over, PS!

1:00 PM – 2:30 PM CEST

COVID-19: Part V

1:00 PM – 2:30 PM CEST

The Pill-osophy of Making Medicines Safe

1:00 PM – 2:30 PM CEST

Lightning Session 2

Plenary Session 3

2:40 PM – 3:50 PM CEST

Annual General Members Meeting & Awards Ceremony

Symposia & Workshops: Session 3

4:15 PM – 5:45 PM CEST

Methodological advances in regulatory Real World Evidence generation systems: Perspectives from Sentinel and DARWIN-EU

4:15 PM – 5:45 PM CEST

Building global consensus on definitions for drug safety studies in pregnancy to improve harmonized evaluation of real-world data

4:15 PM – 5:45 PM CEST

15+ years of ENCePP: what has been achieved, what’s next, and what’s in for ISPE

4:15 PM – 5:45 PM CEST

How can Pharmacoepidemiology research contribute to tackle the Public Health threat of Antimicrobial Resistance? A global approach

4:15 PM – 5:45 PM CEST

Novel Individualized Therapeutics: Challenges and Opportunities for the Use of Real-World Evidence in Rare Diseases

4:15 PM – 5:45 PM CEST

Why Real World Evidence (RWE) Studies Need Implementation Research: The Value Proposition

4:15 PM – 5:45 PM CEST

The growing global problem of drug shortages: Understanding their impact on research, patients and healthcare systems

Oral Presentations: Session 5

8:30 AM – 10:00 AM CEST

Real ID: Methods and Validation in Pregnancy

8:30 AM – 10:00 AM CEST

From Data to Diagnosis: Methods and Applications in Cancer Pharmacoepidemiology

8:30 AM – 10:00 AM CEST

Diabetes Drugs Are Good for the Heart

8:30 AM – 10:00 AM CEST

Lightning Session 3

8:30 AM – 10:00 AM CEST

Vaccine Effectiveness – Beyond COVID-19

8:30 AM – 10:00 AM CEST

Time-travelling Trends

8:30 AM – 10:00 AM CEST

Beyond Borders: Health Disparities in the US and Europe

Symposia & Workshops: Session 4

10:30 AM – 12:00 PM CEST

Risk Minimization Programs for Teratogenic Drugs: How to Move from Art to Science

10:30 AM – 12:00 PM CEST

Target Trial Emulation with Real World Evidence: Regulatory Grade Pharmacoepidemiology in the SIGMA consortium

10:30 AM – 12:00 PM CEST

Using generative AI to more efficiently conduct systematic reviews, solve coding problems, and communicate research findings: a student-led workshop

10:30 AM – 12:00 PM CEST

Data Mining for Drug-Drug Interactions and More

10:30 AM – 12:00 PM CEST

Developing a Roadmap for Foundational Training Courses in Pharmacoepidemiology: A Core Competencies-Based Approach

10:30 AM – 12:00 PM CEST

Back to the Source: a Review of the Current State of Social Determinants of Health in European and US Real World Data Sources

10:30 AM – 12:00 PM CEST

Orchestrating the Data Symphony: Harmoniously Combining Diverse Datasets in External Control Arm Studies in Oncology

Oral Presentations: Session 6

1:30 PM – 3:00 PM CEST

Pediatric Pharmacoepi: Drugs and Bugs Among Us!

1:30 PM – 3:00 PM CEST

Treatment Patterns and Effectiveness and Safety of Anticoagulant Therapy

1:30 PM – 3:00 PM CEST

Surprising Benefits of Diabetes Drugs

1:30 PM – 3:00 PM CEST

A Methods Mischung

1:30 PM – 3:00 PM CEST

Vaccine Safety Potpourri

1:30 PM – 3:00 PM CEST

COVID-19: Now and Later

1:30 PM – 3:00 PM CEST

Mental Health: Treatment Comparative Effectiveness, Dose, Discontinuation, Use and Trends

Plenary Session 4

3:15 PM – 4:45 PM CEST

Hot Topic Session: Should confounding control be based on subject-matter knowledge, or driven by the data? A ‎debate